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A	  Fragile	  	  
Concept	  
	  
BY	  JASON	  KARLAWISH	  
	  
THE	  ALZHEIMER	  CONUNDRUM	  
by	  Margaret	  Lock	  
Princeton	  (NJ):	  Princeton	  University	  Press,	  2014	  




In	  2002	  Margaret	  Lock,	  a	  medical	  anthropologist	  at	  McGill	  University	  in	  Montreal,	  Quebec,	  started	  work	  
on	  a	  book	  about	  the	  social	  implications	  of	  genetic	  testing	  for	  complex	  diseases.	  She	  chose	  Alzheimer’s	  
disease	  as	  her	  case	  study.	  Lock	  soon	  discovered	  that	  she	  had	  stepped	  into	  a	  far	  more	  complex	  and	  
controversial	  situation	  than	  she	  had	  anticipated.	  “Among	  experts,”	  she	  observed,	  “the	  very	  category	  of	  
AD	  [Alzheimer’s	  disease]	  was	  being	  subjected	  to	  questioning	  and	  possibly	  category	  fragmentation	  or	  
reshuffling	  was	  in	  the	  air,	  making	  for	  a	  plethora	  of	  unknowns.”	  
Lock	  set	  out	  to	  explore	  these	  unknowns.	  She	  interviewed	  leading	  Alzheimer’s	  disease	  researchers,	  
attended	  their	  conferences,	  and	  read	  their	  papers.	  She	  conducted	  ethnographic	  interviews	  with	  
clinicians,	  patients,	  and	  their	  caregivers.	  The	  result	  is	  The	  Alzheimer	  Conundrum,	  an	  ambitious	  dissection	  
of	  a	  vexing	  problem:	  Despite	  several	  decades	  of	  research,	  dementia	  remains	  a	  very	  real	  and	  devastating	  
problem	  and	  the	  causes	  of	  the	  most	  common	  form-­‐-­‐Alzheimer’s	  disease-­‐-­‐remain	  elusive.	  Notably,	  the	  
claim	  that	  the	  disease	  is	  distinct	  from	  aging	  is	  increasingly	  unstable.	  This	  conundrum	  has	  clear	  
implications	  for	  what	  the	  United	  States	  should	  do	  to	  prevent	  Alzheimer’s	  disease.	  	  
“Loch_book_review_02_21_14.docx”	  2/24;	  lw	  2/25;	  lw	  to	  dl	  2/25;	  dl	  to	  rl	  2/27;	  rl	  3/	  4;	  lw	  to	  au	  3/	  4;	  
	  
Although	  chapter	  and	  section	  titles	  such	  as	  “An	  Imperialism	  of	  Probabilities”	  and	  “Embodied	  Risk	  Made	  
Visible”	  suggest	  an	  academic	  and	  jargon-­‐filled	  science	  and	  technology	  study,	  The	  Alzheimer	  Conundrum	  
is	  an	  engaging	  read	  that,	  while	  quite	  granular	  in	  its	  detail,	  is	  never	  dry.	  	  
The	  book	  begins	  with	  the	  basic	  premise	  that	  medical	  research	  proceeds	  according	  to	  a	  model	  of	  disease.	  
The	  dominant	  disease	  model	  that	  Alzheimer’s	  researchers	  use	  defines	  disease	  as	  the	  effects	  of	  distinct	  
entities,	  as	  in	  how	  the	  tuberculosis	  bacillus	  causes	  TB.	  In	  the	  case	  of	  diseases	  of	  the	  brain,	  this	  means	  
that	  localized	  pathologies,	  or	  lesions,	  explain	  a	  patient’s	  symptoms,	  in	  the	  manner	  that	  a	  stroke	  in	  the	  
motor	  cortex	  leads	  to	  corresponding	  limb	  weakness.	  In	  the	  particular	  case	  of	  Alzheimer’s	  disease,	  the	  
pathology	  that	  has	  captured	  researchers’	  attention	  is	  plaques	  of	  beta	  amyloid.	  	  
What	  follows	  is	  an	  overview	  of	  the	  twentieth-­‐century	  history	  of	  Alzheimer’s	  disease	  that	  led	  to	  this	  
consolidation	  of	  opinion	  around	  the	  amyloid	  cascade	  hypothesis.	  Subsequent	  chapters	  review	  how	  
biomarker	  measures	  that	  are	  expanding	  the	  disease	  category	  into	  mildly	  impaired	  and	  even	  
asymptomatic	  stages	  have	  also	  destabilized	  the	  tight	  link	  between	  pathology	  and	  disease.	  Lock	  goes	  on	  
to	  examine	  the	  efforts	  of	  genome-­‐wide	  association	  studies-­‐-­‐	  big	  data	  projects	  that,	  she	  argues,	  have	  
expanded	  the	  facts	  about	  Alzheimer’s	  disease	  without	  concomitant	  progress	  in	  understanding	  its	  
causes.	  
Lock	  clearly	  summarizes,	  synthesizes,	  and	  critiques	  the	  results	  from	  research	  in	  molecular	  biology,	  
genetics,	  neuroimaging,	  and	  epidemiology.	  This	  work	  is	  supported	  by	  researchers’	  candid	  and	  
sometimes	  vivid	  reflections	  on	  the	  state	  of	  affairs.	  She	  is	  a	  keen	  observer	  of	  her	  subjects’	  language	  and	  
behaviors:	  how	  some	  have	  described	  those	  findings	  that	  do	  not	  fit	  their	  model	  as	  “junk,”	  “trash,”	  or	  
“garbage,”	  and	  how	  others	  have	  stepped	  outside	  the	  lab	  as	  “rock	  stars	  of	  science,”	  performing	  “The	  
Times	  They	  Are	  a-­‐Changin’”	  with	  Aerosmith’s	  Joe	  Perry	  on	  Capitol	  Hill.	  
“Loch_book_review_02_21_14.docx”	  2/24;	  lw	  2/25;	  lw	  to	  dl	  2/25;	  dl	  to	  rl	  2/27;	  rl	  3/	  4;	  lw	  to	  au	  3/	  4;	  
	  
Lock	  has	  discovered	  that	  the	  dominant	  concept	  of	  Alzheimer’s	  disease	  is	  in	  fact	  fragile.	  Plaque	  
accumulation	  does	  not	  map	  onto	  a	  lesion-­‐based	  disease	  model.	  Reducing	  the	  cause	  of	  Alzheimer’s	  
disease	  to	  amyloid	  or	  other	  molecules	  ignores	  research	  showing	  that	  many	  older	  adults’	  have	  brains	  
filled	  with	  pathology,	  but	  they	  live	  disease-­‐free	  lives.	  Alzheimer’s	  disease	  and	  aging	  are	  not	  distinct	  
boxes	  in	  a	  periodic	  table;	  they	  are	  neighboring	  territories	  separated	  by	  man-­‐made	  borders.	  	  
The	  book	  concludes	  with	  an	  ambitious	  summary	  of	  studies	  in	  epigenetics,	  genomics,	  and	  epidemiology	  
whose	  results	  suggest	  that	  the	  many	  genes	  and	  molecules	  linked	  to	  Alzheimer’s	  disease	  are	  in	  a	  dynamic	  
interaction	  with	  both	  their	  cellular	  and	  external	  environments.	  This,	  she	  argues,	  supports	  an	  alternative	  
model	  of	  disease-­‐-­‐an	  “entanglement	  theory”-­‐-­‐that	  sees	  the	  aging	  brain	  and	  the	  world	  in	  a	  disrupted	  
equilibrium,	  which,	  she	  argues,	  compels	  researchers	  to	  move	  from	  conceptualizing	  Alzheimer’s	  disease	  
as	  caused	  by	  problems	  in	  the	  brain	  alone,	  to	  a	  problem	  of	  the	  person	  in	  their	  environmental,	  social,	  and	  
political	  milieus.	  	  
The	  Alzheimer	  Conundrum	  arrives	  at	  an	  auspicious	  time.	  The	  United	  States	  has	  committed	  itself	  to	  
preventing	  Alzheimer’s	  disease	  by	  2025.	  This	  research	  supports	  partnerships	  among	  academics,	  the	  
National	  Institutes	  of	  Health,	  and	  pharmaceutical	  companies	  whose	  goal	  is	  to	  discover	  targeted	  
molecular	  diagnostics	  and	  therapeutics.	  Good	  data	  support	  these	  studies.	  The	  Alzheimer	  Conundrum	  
suggests	  that	  efforts	  such	  as	  the	  Center	  for	  Disease	  Control’s	  Healthy	  Brain	  Initiative	  will	  increase	  our	  
odds	  of	  success.	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